biodisponibilité relative

CONT: Bioavailability refers to the rate and extent to which the API [active pharmaceutical ingredient], or its active moiety, is absorbed from a pharmaceutical product and becomes available at the site of action. It may be useful to distinguish between the ""absolute bioavailability"" of a given dosage form as compared with that (100%) following intravenous administration (e.g., oral solution vs. intravenous), and the ""relative bioavailability"" as compared with another form administered by the same or another non-intravenous route (e.g., tablets vs. oral solution).